Is HELE a Buy or a Sell? The Bull and Bear Case (2026)
Last updated July 2026
Short answer
Both cases are real, which is why the question is contested. The bull case for Helen of Troy Limited (HELE) rests on Leadership Brand portfolio: Helen of Troy concentrates investment behind a handful of scaled brands including OXO, Hydro Flask, Osprey, Vicks, Braun and Honeywell. The bear case rests on revenue has been declining, and a rebound is not guaranteed given consumer discretionary softness and competitive private-label pressure. Analysts covering it publish targets from $25.00 to $40.00 against a $28.34 price, so even the professionals disagree by 48% of their own average. We do not give a verdict. What follows is each case at full strength, so you can decide which set of assumptions you actually believe. Walnut is not an investment adviser.
Helen of Troy Limited designs, markets and distributes consumer products across two segments: Home & Outdoor (OXO kitchen and storage tools, Hydro Flask hydration bottles, Osprey packs, PUR filtration) and Beauty & Wellness (Braun and Vicks health devices, Honeywell air treatment, Hot Tools and Drybar hair appliances, Curlsmith). The company sells through mass retail, specialty, and online channels, and manages a portfolio it calls its Leadership Brands while periodically acquiring and divesting smaller labels. Trailing revenue is roughly $1.80 billion (as of June 2026), and the business generates meaningful free cash flow even as top-line sales have softened. The investment picture is that of a leveraged turnaround. HELE reported a large GAAP net loss (~$899 million) driven mainly by an ~$886 million non-cash goodwill and intangibles writedown, while adjusted profitability and free cash flow stayed positive and the company paid down debt toward ~$716 million (as of June 2026). With a market cap near $641 million against ~$1.80 billion of sales, the stock trades at a low price-to-sales multiple that reflects real concerns: declining sales at some Leadership Brands, tariff exposure on imported goods, and a debt load that constrains flexibility. Bulls focus on cash generation, cost restructuring (the Pegasus program) and cheap valuation; bears point to shrinking revenue and balance-sheet risk.
The bull case: what would have to be true for $40.00
The most optimistic published target on HELE is $40.00, +41.1% from the $28.34 price as of July 2026. Getting there needs the following to work close to its best case, not merely to avoid going wrong.
1. Leadership Brand portfolio
Helen of Troy concentrates investment behind a handful of scaled brands including OXO, Hydro Flask, Osprey, Vicks, Braun and Honeywell. Performance is uneven across the portfolio (Osprey has grown while Hydro Flask has slipped in recent quarters), so the near-term story is about stabilizing the softer brands while defending share in the stronger ones.
2. Cost restructuring and cash flow
The Pegasus and related restructuring programs aim to cut costs, simplify operations and lift margins. Even with declining sales, the company has produced solid free cash flow (over $100 million in a single recent quarter as of June 2026), which it has been directing toward debt reduction rather than buybacks or a dividend.
3. Debt paydown and balance sheet
With total debt around $716 million and a debt-to-equity ratio above 1.0 (as of June 2026), deleveraging is central to the thesis. Continued free cash flow that reduces borrowings would lower interest expense and financial risk, while any cash-flow shortfall would leave the balance sheet stretched.
4. Tariff and cost management
Much of Helen of Troy's product is sourced abroad, so tariffs and input costs directly pressure gross margin, which compressed to roughly 44.6% in the latest quarter (as of June 2026). Management guidance and pricing actions are aimed at absorbing these headwinds, and the market has reacted sharply to quarters that beat lowered expectations.
The bear case: what would have to be true for $25.00
The most pessimistic published target is $25.00, -11.8% from the current price. That is not a floor and not a forecast; it is roughly what one analyst thinks Helen of Troy Limited is worth if the risks below bite instead of the drivers above.
Revenue has been declining, and a rebound is not guaranteed given consumer discretionary softness and competitive private-label pressure. The company carries meaningful debt (~$716 million as of June 2026), so a downturn in cash flow would raise refinancing and covenant risk. Tariffs and imported-goods costs weigh on margins, and the large recent goodwill writedown signals that past acquisitions were carried above their current worth. HELE pays no dividend, and the low market capitalization relative to sales reflects genuine uncertainty rather than a guaranteed value opportunity.
The bear case deserves the same attention as the bull case, and usually gets less. If you are holding HELE already, the question is not whether these risks exist but whether any of them has moved from possible to actually happening in the reported numbers.
Where analysts land on HELE
3 analysts cover HELE, with an average target of $31.00 (+9.4% against $28.34) and a split of 1 buy, 3 hold, 0 sell. Bear in mind sell-side ratings skew positive across the whole market, so that split is not a balanced vote. The full target table, the recent rating actions by firm, and how the consensus has shifted are on the HELE forecast and price target page.
How is HELE valued? (as of JUNE 2026)
Snapshot for HELE as of July 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.
- Revenue (TTM): ~$1.80 billion
- Market cap: ~$641 million
- Q4 FY2026 net sales: ~$470 million
- Q4 FY2026 adjusted EPS: ~$0.83
- Total debt: ~$716 million
- FY2027 net sales guidance: ~$1.76 to $1.83 billion
HELE trades at a low price-to-sales multiple (market cap roughly a third of trailing revenue as of June 2026), which reflects declining sales and a leveraged balance sheet rather than a clear bargain. A large non-cash goodwill and intangibles writedown (~$886 million) drove a sizable GAAP net loss, while adjusted earnings and free cash flow remained positive. Valuation multiples on GAAP earnings are distorted by that charge, so cash flow and sales trends are the more useful gauges here.
How do you decide if HELE is a buy?
Rather than asking whether HELE is a buy in the abstract, it tends to help to answer four questions:
- Thesis: do you believe the bull case above, and is it still true today?
- Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
- Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
- Overlap: check whether you already hold HELE indirectly through an index or sector ETF before adding more.
What would change your mind on HELE
Write the tripwires down before you need them. Deciding what would falsify your view is far harder once a position is moving against you.
- Bull case breaks if: Leadership Brand portfolio stalls in the reported numbers rather than in the narrative around them.
- Bear case breaks if: revenue has been declining, and a rebound is not guaranteed given consumer discretionary softness and competitive private-label pressure fails to materialise over several reporting periods while the drivers keep compounding.
- Neither matters if: the position has grown large enough that being wrong would damage the whole portfolio. Sizing overrides the argument.
For the full picture, see the HELE stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about HELE against your real portfolio and see your actual exposure before deciding.
Investing in Helen of Troy Limited with AI
Connect the broker you already use and ask Walnut's AI how HELE fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
Is HELE a good stock to buy right now?
+
That depends on which case you find more convincing, and both are on this page. The bull case rests on Leadership Brand portfolio, with revenue (ttm) at ~$1.80 billion. The bear case rests on revenue has been declining, and a rebound is not guaranteed given consumer discretionary softness and competitive private-label pressure. Analysts covering it are spread from $25.00 to $40.00, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.
Should I sell HELE?
+
Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. Revenue has been declining, and a rebound is not guaranteed given consumer discretionary softness and competitive private-label pressure. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $25.00, -11.8% from the $28.34 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.
What is the bull case for HELE?
+
Leadership Brand portfolio. Helen of Troy concentrates investment behind a handful of scaled brands including OXO, Hydro Flask, Osprey, Vicks, Braun and Honeywell. The most optimistic analyst target on HELE is $40.00, +41.1% from the $28.34 price. That figure is only reachable if this thesis works close to its best case.
What is the bear case for HELE?
+
Revenue has been declining, and a rebound is not guaranteed given consumer discretionary softness and competitive private-label pressure. The company carries meaningful debt (~$716 million as of June 2026), so a downturn in cash flow would raise refinancing and covenant risk. Tariffs and imported-goods costs weigh on margins, and the large recent goodwill writedown signals that past acquisitions were carried above their current worth. HELE pays no dividend, and the low market capitalization relative to sales reflects genuine uncertainty rather than a guaranteed value opportunity. The most pessimistic published target is $25.00, -11.8% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.
What does Helen of Troy Limited do?
+
Helen of Troy Limited designs, markets and distributes consumer products across two segments: Home & Outdoor (OXO kitchen and storage tools, Hydro Flask hydration bottles, Osprey p
What would have to change for HELE to stop being worth holding?
+
Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Leadership Brand portfolio) stalling in the reported numbers rather than in the narrative, the risk above (revenue has been declining, and a rebound is not guaranteed given consumer discretionary softness and competitive private-label pressure) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.
What does Helen of Troy do?
+
It designs, markets and distributes consumer products across two segments, Home & Outdoor and Beauty & Wellness, under brands including OXO, Hydro Flask, Osprey, Vicks, Braun, Honeywell, PUR, Hot Tools and Drybar. It sells through retail, specialty and online channels.
Why is Helen of Troy stock so cheap relative to its sales?
+
As of June 2026 the market cap (~$641 million) is roughly a third of trailing revenue (~$1.80 billion). The low multiple reflects declining sales, tariff pressure on margins, meaningful debt (~$716 million) and a large recent goodwill writedown, not a settled bargain.
Did Helen of Troy report a big loss?
+
It reported a large GAAP net loss (~$899 million as of June 2026), but the bulk came from a non-cash goodwill and intangibles writedown of roughly $886 million. Adjusted earnings and free cash flow stayed positive over the same period.
Walnut is informational, not investment advice, and gives no verdict on HELE. Analyst targets referenced here come from a July 2026 pull of published third-party research and change constantly. Verify current figures with your broker before acting on them.